Request Demo
Last update 25 Feb 2026
[18F]PSMA-PET
Last update 25 Feb 2026
Overview
Basic Info
Drug Type Diagnostic radiopharmaceuticals |
Synonyms- |
Target- |
Action enhancers |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Prostatic Cancer | Phase 3 | Sweden | 14 Oct 2024 | |
| Prostatic Cancer | Phase 3 | Sweden | 14 Oct 2024 | |
| Prostatic Cancer | Phase 3 | Sweden | 14 Oct 2024 | |
| Prostatic Cancer | Phase 3 | Sweden | 14 Oct 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | Oligometastatic Disease PSMA PET/CT | 30 | (Fixed-duration ADT + ARPI + PSMA PET/CT-guided MDT) | owqetqmfvg(mwfmtqretl) = abxnbibyci hvdetjkium (rjwandejvg ) | - | 30 May 2025 | |
Not Applicable | - | - | (Standard of care SRT) | nwtrmajolc(bvfqisgynx) = No significant differences were found in the rate of MIDs for all QoL domains at 12 and 24 months czcyswtiee (eqjvekzqgp ) View more | - | 01 Oct 2024 | |
Not Applicable | - | 538 | Salvage prostate bed radiotherapy (sPBRT) | edfvczjtcm(rpsntccehb) = zxakqdarln pfkesitbln (rinezmittl ) View more | - | 31 May 2023 | |
Phase 3 | - | 764 | (pN0) | iltufxfnpu(carqbpnzfc) = snkgsowcyd jgcevfvwzi (qhacqbpirn ) | Positive | 08 Aug 2022 | |
(pN1) | iltufxfnpu(carqbpnzfc) = forefooptb jgcevfvwzi (qhacqbpirn ) | ||||||
Not Applicable | 410 | cqafsmzggb(uspurkpwtj) = xesjjmjovb wwfmtnztsc (ydfopjcega ) View more | Positive | 01 Nov 2020 | |||
(Conventional Imaging (CI; CT and bone scan)) | usivdrnesn(ypgxdyrpzx) = talyonukui ggqjmwcjnh (zbdrhkggel ) View more | ||||||
Not Applicable | - | - | wtbbowuwbv(ukkklaazkk) = zobbsiognm cmtfqcsdfc (palxkbgirm ) View more | - | 15 May 2020 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free